SeQuent Scientific Ltd
NSE:SEQUENT

Watchlist Manager
SeQuent Scientific Ltd Logo
SeQuent Scientific Ltd
NSE:SEQUENT
Watchlist
Price: 206.8 INR -0.07% Market Closed
Market Cap: 52.2B INR

SeQuent Scientific Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

SeQuent Scientific Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
SeQuent Scientific Ltd
NSE:SEQUENT
Revenue
₹16B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
13%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Revenue
₹343.1B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
16%
Cipla Ltd
NSE:CIPLA
Revenue
₹283.5B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
8%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Revenue
₹549.6B
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
8%
Lupin Ltd
NSE:LUPIN
Revenue
₹247.5B
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
7%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Revenue
₹122.5B
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
7%
No Stocks Found

SeQuent Scientific Ltd
Glance View

Market Cap
51.8B INR
Industry
Pharmaceuticals

SeQuent Scientific Ltd. manufactures and produces veterinary pharmaceuticals and specialty chemicals. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-10. The firm operates in the domains of animal health, in which it provides active pharmaceutical ingredient (APIs) and finished dosage formulations, and analytical services. The firm through its subsidiary, Alivira Animal Health Limited, offers APIs and formulations. Alivira Animal Health Limited has manufacturing facilities in five countries, including India. The Company’s subsidiary, Sequent Research Limited, is a contract research organization, which is engaged in analytical and biological analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. Sequent Research Limited provides complete analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopeial monographs, customer-developed methods or in-house method development.

SEQUENT Intrinsic Value
99.55 INR
Overvaluation 52%
Intrinsic Value
Price

See Also

What is SeQuent Scientific Ltd's Revenue?
Revenue
16B INR

Based on the financial report for Jun 30, 2025, SeQuent Scientific Ltd's Revenue amounts to 16B INR.

What is SeQuent Scientific Ltd's Revenue growth rate?
Revenue CAGR 10Y
13%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for SeQuent Scientific Ltd have been 4% over the past three years , 6% over the past five years , and 13% over the past ten years .

Back to Top